Click here to read the articles and download the PDF

Pharmaceutical Commerce - February 2025

Leaders with top third-party logistics providers discuss the evolving landscape for the sector in 2025—and the new strides made in their quest to help transform the pharma supply chain.

3PLs: From Resilience to Sustainability

What factors should be considered—and how can both parties benefit long-term?

M&A in Pharma: Balancing Growth and Risk

How chain and local closures are impacting healthcare access.

The Prominence of Pharmacy Deserts

Articles

In a move meant to encourage domestic production, the president’s executive order features a 10% baseline tax, expected to take effect April 9. 

Trump Issues New Reciprocal Tariffs

Videos

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Colin Banas, MD, DrFirst’s chief medical officer, explains the rise in patients turning to DTC platforms following insurance denials.

The Growing Role of DTC Healthcare

In the first part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Rachel Thorpe, executive director at the Otsuka Patient Assistance Foundation, describes the various conference sessions that she participated in. 

PAP 2025: Establishing and Transitioning to a Foundation 

The latest news for pharma industry insiders.

Pharma Pulse 4/3/25: Analyzing the Theranos Appeals, Current CAR-T Therapy Trends in Managed Care & more

The telehealth company is offering Lilly’s branded form of tirzepatide—approved for weight loss—on its site for $1,899 a month, while Lilly also sells the GLP-1 via its LillyDirect platform.

Hims & Hers Begins Selling Zepbound

In the first part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Kimberly Westrich, chief strategy officer at the National Pharmaceutical Council, lays out the basics surrounding accumulators, maximizers, and AFPs. 

Hubs East 2025: Understanding Copay Accumulators, Maximizers, and Alternative Funding Programs

Pharma Pulse 4/2/25: Balancing Cost-Efficiency with Domestic Manufacturing Need, Making M3P Work for Your Pharmacy & more

CRYOPDP—centered around clinical trials, biopharma, and cell and gene therapies—augments DHL’s specialty pharma logistics expertise.

DHL Purchases Cryoport’s Specialty Courier

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Colin Banas, MD, DrFirst’s chief medical officer, discusses the challenges that many Americans face regarding the affordability of GLP-1 drugs.

Featured Content

Pharmaceutical Commerce - February 2025

3PLs: From Resilience to Sustainability

M&A in Pharma: Balancing Growth and Risk

The Prominence of Pharmacy Deserts